Moderna, Inc. SEC filings MRNA
Moderna, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Mar 30, 2021. Its latest annual report, Form ARS, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 31, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 30, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 5, 2026 | — |
| 4 | Insider transaction | Oct 16, 2026 | Oct 14, 2026 |
| 144 | Notice of proposed sale | Oct 15, 2026 | — |
| 144 | Notice of proposed sale | Oct 14, 2026 | — |
| 4 | Insider transaction | Oct 7, 2026 | Oct 5, 2026 |
| 3 | Initial insider ownership | Oct 5, 2026 | Oct 5, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 30, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Sep 16, 2026 | Sep 14, 2026 |
| 144 | Notice of proposed sale | Sep 15, 2026 | — |
| 4 | Insider transaction | Sep 14, 2026 | Sep 10, 2026 |
| 144 | Notice of proposed sale | Sep 14, 2026 | — |
| 144 | Notice of proposed sale | Sep 10, 2026 | — |
| 4 | Insider transaction | Sep 8, 2026 | Sep 4, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 4, 2026 |
| 4 | Insider transaction | Sep 3, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Sep 3, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Sep 3, 2026 | Sep 1, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Sep 1, 2026 | Aug 27, 2026 |
| 144 | Notice of proposed sale | Sep 1, 2026 | — |
| 4 | Insider transaction | Aug 31, 2026 | Aug 27, 2026 |
| 4 | Insider transaction | Aug 31, 2026 | Aug 27, 2026 |
| 4 | Insider transaction | Aug 31, 2026 | Aug 27, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 12, 2026 | — |
| 4 | Insider transaction | Aug 7, 2026 | Aug 5, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 6, 2026 | — |
| 144 | Notice of proposed sale | Aug 5, 2026 | — |
| 10-Q | Quarterly report | Jul 31, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 31, 2026 | Jul 31, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 24, 2026 | — |
| 4 | Insider transaction | Jul 16, 2026 | Jul 15, 2026 |
| 144 | Notice of proposed sale | Jul 15, 2026 | — |
| 4 | Insider transaction | Jul 10, 2026 | Jul 8, 2026 |
| 3 | Initial insider ownership | Jul 10, 2026 | Jul 8, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 8, 2026 | Jul 6, 2026 |
| 4 | Insider transaction | Jul 7, 2026 | Jul 5, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jul 2, 2026 |
| 3 | Initial insider ownership | Jun 30, 2026 | Jun 15, 2026 |
| 144 | Notice of proposed sale | Jun 18, 2026 | — |
| 4 | Insider transaction | Jun 17, 2026 | Jun 15, 2026 |
| 144 | Notice of proposed sale | Jun 15, 2026 | — |
| 4 | Insider transaction | Jun 8, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 144 | Notice of proposed sale | Jun 4, 2026 | — |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 27, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 27, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 27, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 21, 2026 |
| 144 | Notice of proposed sale | May 21, 2026 | — |
| 4 | Insider transaction | May 18, 2026 | May 15, 2026 |
| 144 | Notice of proposed sale | May 15, 2026 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 11, 2026 | May 6, 2026 |
| 4 | Insider transaction | May 8, 2026 | May 6, 2026 |
| 4 | Insider transaction | May 8, 2026 | May 6, 2026 |
| 4 | Insider transaction | May 8, 2026 | May 6, 2026 |
| 4 | Insider transaction | May 8, 2026 | May 6, 2026 |
| 4 | Insider transaction | May 8, 2026 | May 6, 2026 |
| 4 | Insider transaction | May 8, 2026 | May 6, 2026 |
| 4 | Insider transaction | May 8, 2026 | May 6, 2026 |
| 144 | Notice of proposed sale | May 8, 2026 | — |
| 4 | Insider transaction | May 4, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | May 4, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | May 4, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | May 4, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | May 4, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | May 4, 2026 | Apr 30, 2026 |
| 10-Q | Quarterly report | May 1, 2026 | Mar 31, 2026 |
| 144 | Notice of proposed sale | May 1, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 1, 2026 | May 1, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 30, 2026 | — |
| 4 | Insider transaction | Apr 6, 2026 | Apr 2, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 27, 2026 | — |
| DEFA14A | Additional proxy material | Mar 16, 2026 | — |
| DEF 14A | Proxy statement | Mar 16, 2026 | May 6, 2026 |
| ARS | Annual report to shareholders | Mar 16, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 5, 2026 |
| 8-K |
Current report
Material agreement
|
Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| 4 | Insider transaction | Feb 25, 2026 | Feb 23, 2026 |
| 144 | Notice of proposed sale | Feb 23, 2026 | — |
| S-8 | Employee stock plan registration | Feb 20, 2026 | — |
| 10-K | Annual report | Feb 20, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 13, 2026 | Feb 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 11, 2026 | Feb 3, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 9, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 6, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 5, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 5, 2026 | Jan 5, 2026 |
| SC TO-I/A | Filing | Dec 16, 2025 | — |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 144 | Notice of proposed sale | Dec 11, 2025 | — |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 144 | Notice of proposed sale | Dec 9, 2025 | — |
| 4 | Insider transaction | Dec 8, 2025 | Dec 5, 2025 |
| 4 | Insider transaction | Dec 8, 2025 | Dec 5, 2025 |
| 4 | Insider transaction | Dec 2, 2025 | Dec 1, 2025 |
| 4 | Insider transaction | Dec 2, 2025 | Dec 1, 2025 |
| 4 | Insider transaction | Dec 1, 2025 | Nov 26, 2025 |
| 4 | Insider transaction | Dec 1, 2025 | Nov 26, 2025 |
| 4 | Insider transaction | Dec 1, 2025 | Nov 26, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Nov 24, 2025 | Nov 19, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 20, 2025 | Nov 20, 2025 |
| SC TO-I/A | Filing | Nov 18, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Nov 13, 2025 | Nov 12, 2025 |
| SC TO-I | Filing | Nov 13, 2025 | — |
| SC TO-C | Filing | Nov 12, 2025 | — |
| SC TO-C | Filing | Nov 6, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 5, 2025 | — |
| SC TO-C | Filing | Oct 21, 2025 | — |
| DEFA14A | Additional proxy material | Oct 20, 2025 | — |
| DEF 14A | Proxy statement | Oct 15, 2025 | Nov 12, 2025 |
| SC TO-C | Filing | Oct 10, 2025 | — |
| 4 | Insider transaction | Oct 6, 2025 | Oct 3, 2025 |
| 4 | Insider transaction | Oct 6, 2025 | Oct 2, 2025 |
| SC TO-C | Filing | Oct 3, 2025 | — |
| PRE 14A | Preliminary proxy statement | Oct 3, 2025 | Nov 12, 2025 |
| 4 | Insider transaction | Sep 2, 2025 | Aug 29, 2025 |
| 4 | Insider transaction | Sep 2, 2025 | Aug 29, 2025 |
| 4 | Insider transaction | Aug 29, 2025 | Aug 27, 2025 |
| 4 | Insider transaction | Aug 29, 2025 | Aug 27, 2025 |
| 4 | Insider transaction | Aug 29, 2025 | Aug 27, 2025 |
| 4 | Insider transaction | Aug 6, 2025 | Aug 5, 2025 |
| 10-Q | Quarterly report | Aug 1, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2025 | Aug 1, 2025 |
| 4 | Insider transaction | Jul 7, 2025 | Jul 3, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 11, 2025 |
| 144 | Notice of proposed sale | Jun 11, 2025 | — |
| 4 | Insider transaction | Jun 9, 2025 | Jun 6, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 30, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 30, 2025 |
| 4 | Insider transaction | May 29, 2025 | May 27, 2025 |
| 4 | Insider transaction | May 29, 2025 | May 27, 2025 |
| 4 | Insider transaction | May 29, 2025 | May 27, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 12, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
May 5, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 1, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 1, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 1, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 1, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 1, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 1, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 1, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 1, 2025 | Apr 30, 2025 |
| 10-Q | Quarterly report | May 1, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 1, 2025 | May 1, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 30, 2025 | — |
| 4 | Insider transaction | Apr 7, 2025 | Apr 4, 2025 |
| DEFA14A | Additional proxy material | Mar 11, 2025 | — |
| DEF 14A | Proxy statement | Mar 11, 2025 | Apr 30, 2025 |
| ARS | Annual report to shareholders | Mar 11, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Mar 10, 2025 | Mar 7, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 27, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 27, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 27, 2025 |
| S-8 | Employee stock plan registration | Feb 21, 2025 | — |
| 10-K | Annual report | Feb 21, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 12, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 12, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 12, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 14, 2025 | Feb 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| 4 | Insider transaction | Feb 10, 2025 | Feb 7, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Dec 10, 2024 | Dec 6, 2024 |
| 144 | Notice of proposed sale | Dec 9, 2024 | — |
| 4 | Insider transaction | Dec 6, 2024 | Dec 5, 2024 |
| 4 | Insider transaction | Dec 6, 2024 | Dec 5, 2024 |
| 4 | Insider transaction | Dec 4, 2024 | Dec 2, 2024 |
| 4 | Insider transaction | Dec 4, 2024 | Dec 2, 2024 |
| 144 | Notice of proposed sale | Dec 3, 2024 | — |
| 144 | Notice of proposed sale | Dec 3, 2024 | — |
| 4 | Insider transaction | Dec 2, 2024 | Nov 27, 2024 |
| 4 | Insider transaction | Dec 2, 2024 | Nov 27, 2024 |
| 4 | Insider transaction | Dec 2, 2024 | Nov 27, 2024 |
| 144 | Notice of proposed sale | Nov 29, 2024 | — |
| 144 | Notice of proposed sale | Nov 29, 2024 | — |
| 144 | Notice of proposed sale | Nov 29, 2024 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- MRNA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1682852
- Former names
- Moderna Therapeutics, Inc. (until Aug 24, 2016)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
- Neurocrine Biosciences Inc NBIX
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.